190 related articles for article (PubMed ID: 18443602)
1. Inhibition of respiratory syncytial virus infections with morpholino oligomers in cell cultures and in mice.
Lai SH; Stein DA; Guerrero-Plata A; Liao SL; Ivanciuc T; Hong C; Iversen PL; Casola A; Garofalo RP
Mol Ther; 2008 Jun; 16(6):1120-8. PubMed ID: 18443602
[TBL] [Abstract][Full Text] [Related]
2. Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus.
Gabriel G; Nordmann A; Stein DA; Iversen PL; Klenk HD
J Gen Virol; 2008 Apr; 89(Pt 4):939-948. PubMed ID: 18343835
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of foot-and-mouth disease virus infections in cell cultures with antisense morpholino oligomers.
Vagnozzi A; Stein DA; Iversen PL; Rieder E
J Virol; 2007 Nov; 81(21):11669-80. PubMed ID: 17728223
[TBL] [Abstract][Full Text] [Related]
4. Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers.
Eide K; Moerdyk-Schauwecker M; Stein DA; Bildfell R; Koelle DM; Jin L
Antivir Ther; 2010; 15(8):1141-9. PubMed ID: 21149921
[TBL] [Abstract][Full Text] [Related]
5. CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats.
Green G; Johnson SM; Costello H; Brakel K; Harder O; Oomens AG; Peeples ME; Moulton HM; Niewiesk S
J Virol; 2021 Jul; 95(16):e0001021. PubMed ID: 34037420
[TBL] [Abstract][Full Text] [Related]
6. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction.
Moore ML; Chi MH; Luongo C; Lukacs NW; Polosukhin VV; Huckabee MM; Newcomb DC; Buchholz UJ; Crowe JE; Goleniewska K; Williams JV; Collins PL; Peebles RS
J Virol; 2009 May; 83(9):4185-94. PubMed ID: 19211758
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of RNA virus infections with peptide-conjugated morpholino oligomers.
Stein DA
Curr Pharm Des; 2008; 14(25):2619-34. PubMed ID: 18991679
[TBL] [Abstract][Full Text] [Related]
8. In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus.
Deas TS; Bennett CJ; Jones SA; Tilgner M; Ren P; Behr MJ; Stein DA; Iversen PL; Kramer LD; Bernard KA; Shi PY
Antimicrob Agents Chemother; 2007 Jul; 51(7):2470-82. PubMed ID: 17485503
[TBL] [Abstract][Full Text] [Related]
9. Ultrafine carbon black particles enhance respiratory syncytial virus-induced airway reactivity, pulmonary inflammation, and chemokine expression.
Lambert AL; Mangum JB; DeLorme MP; Everitt JI
Toxicol Sci; 2003 Apr; 72(2):339-46. PubMed ID: 12655033
[TBL] [Abstract][Full Text] [Related]
10. Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective.
Boyoglu-Barnum S; Todd SO; Meng J; Barnum TR; Chirkova T; Haynes LM; Jadhao SJ; Tripp RA; Oomens AG; Moore ML; Anderson LJ
J Virol; 2017 May; 91(10):. PubMed ID: 28275196
[TBL] [Abstract][Full Text] [Related]
11. IkappaB kinase is a critical regulator of chemokine expression and lung inflammation in respiratory syncytial virus infection.
Haeberle HA; Casola A; Gatalica Z; Petronella S; Dieterich HJ; Ernst PB; Brasier AR; Garofalo RP
J Virol; 2004 Mar; 78(5):2232-41. PubMed ID: 14963119
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B Virus Core Particles Containing a Conserved Region of the G Protein Combined with Interleukin-35 Protected Mice against Respiratory Syncytial Virus Infection without Vaccine-Enhanced Immunopathology.
Yang J; Ma C; Zhao Y; Fan A; Zou X; Pan Z
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321805
[TBL] [Abstract][Full Text] [Related]
13. Effect of preexposure to ultrafine carbon black on respiratory syncytial virus infection in mice.
Lambert AL; Trasti FS; Mangum JB; Everitt JI
Toxicol Sci; 2003 Apr; 72(2):331-8. PubMed ID: 12660365
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus upregulates IL-33 expression in mouse model of virus-induced inflammation exacerbation in OVA-sensitized mice and in asthmatic subjects.
Nikonova A; Shilovskiy I; Galitskaya M; Sokolova A; Sundukova M; Dmitrieva-Posocco O; Mitin A; Komogorova V; Litvina M; Sharova N; Zhernov Y; Kudlay D; Dvornikov A; Kurbacheva O; Khaitov R; Khaitov M
Cytokine; 2021 Feb; 138():155349. PubMed ID: 33132030
[TBL] [Abstract][Full Text] [Related]
15. Stable Attenuation of Human Respiratory Syncytial Virus for Live Vaccines by Deletion and Insertion of Amino Acids in the Hinge Region between the mRNA Capping and Methyltransferase Domains of the Large Polymerase Protein.
Xue M; Wang R; Harder O; Chen P; Lu M; Cai H; Li A; Liang X; Jennings R; La Perle K; Niewiesk S; Peeples ME; Li J
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999025
[TBL] [Abstract][Full Text] [Related]
16. Long-Lasting Protection Induced by a Polyanhydride Nanovaccine against Respiratory Syncytial Virus in an Outbred Mouse Model.
Stephens LM; Ross KA; McLellan JS; Narasimhan B; Varga SM
J Virol; 2022 Nov; 96(22):e0150222. PubMed ID: 36314826
[TBL] [Abstract][Full Text] [Related]
17. A Novel Live Attenuated Respiratory Syncytial Virus Vaccine Candidate with Mutations in the L Protein SAM Binding Site and the G Protein Cleavage Site Is Protective in Cotton Rats and a Rhesus Macaque.
Jenkins T; Wang R; Harder O; Xue M; Chen P; Corry J; Walker C; Teng M; Mejias A; Ramilo O; Niewiesk S; Li J; Peeples ME
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177201
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 4-mediated respiratory syncytial virus disease and lung transcriptomics in differentially susceptible inbred mouse strains.
Marzec J; Cho HY; High M; McCaw ZR; Polack F; Kleeberger SR
Physiol Genomics; 2019 Dec; 51(12):630-643. PubMed ID: 31736414
[TBL] [Abstract][Full Text] [Related]
19. Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs.
Salinas FM; Nebreda AD; Vázquez L; Gentilini MV; Marini V; Benedetti M; Nabaes Jodar MS; Viegas M; Shayo C; Bueno CA
Antiviral Res; 2020 Jul; 179():104817. PubMed ID: 32387475
[TBL] [Abstract][Full Text] [Related]
20. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection.
Kong X; Hellermann GR; Patton G; Kumar M; Behera A; Randall TS; Zhang J; Lockey RF; Mohapatra SS
Virol J; 2005 Feb; 2():3. PubMed ID: 15701174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
